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We reviewed 180 electroneuromyographic (EMG) studies from patients 
with acute inflammatory demyelinating polyradiculoneuropathy. EMG 
criteria suggestive of demyelination were met during the first 5 weeks in 
87% of patients; an additional 10% had indeterminate electrodiagnostic 
evaluations, and 3% demonstrated axonal degeneration only. Motor 
nerve conduction abnormalities initially predominated, with the nadir 
of abnormality occurring at week 3. Sensory nerve conduction abnor- 
malities peaked during week 4 and were atypical for polyneuropathy, 
with 52% of patients having normal sural but abnormal median sensory 
studies, perhaps reflecting distal nerve involvement. Delayed sensory 
abnormalities may reflect, in part, secondary involvement related to 
increased intraneural edema accentuated by compression at sites of 
anatomic vulnerability. Fibrillation potentials and increased polyphasia 
appeared between weeks 2 and 5 in proximal and distal muscles simul- 
taneously, which is consistent with either random axonal degeneration 
at any point along the axon or distal involvement. Resolution of con- 
duction abnormalities began between weeks 6 and 10, with increased 
mean motor-evoked amplitude best reflecting functional clinical re- 
covery. 
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SEQUENTIAL ELECTRODIAGNOSTIC 
ABNORMALITIES IN ACUTE INFLAMMATORY 
DEMYELINATING POLYRADICULONEUROPATHY 
JAMES W. ALBERS, MD, PhD, PETER D. DONOFRIO, MD, 
and TIMOTHY K. McGONAGLE, MD 
A variety of electrodiagnostic findings have been 
reported for patients with acute inflamniatory demy- 
elinating polyradiculoneuropathy (AIDP) (acute 
idiopathic polyradiculotieuritis, Guillain-Barre 
syndrome [ ~ B S ] ) . ~ . ~ . ~ ~ . ~ X , " . " . ~ ~ ;  The reported ab- 
normalities are thought to reflect both the m u -  
tifocal nature of the disorder arid the combination 
of demyelination with varying amounts of second- 
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ai-y axorial degeneration. In addition, the \wiaI)le 
electrodiagnostic findings unquestionaldy 1-ellect 
the time at which studies are performed relative t o  
disease onset, recognizing that tempoIiil changes 
occur in response to  cumulative dernyelination 
and axonal degeneration. Surprisingly, teniporiil 
findings in conventional electrodiahrnosis have rc- 
ceived little consideration." Patients Lvith AIDP 
frequently have multiple electrodiagnostic evalua- 
tions, either to clarify the diagnosis o r  to establish 
the prognosis. We revie\ved our experience over a 
3-year period with the electrodiagnostic ev:iluation 
of patients fulfilling clinical criteria fiw AI1)I'. 
Findings were grouped as a function of time af'ter 
onset of neurologic symptoms to see if'this resulted 
in identification of specilic electrodiagnostic pat- 
terns that were not previously appreciated. I n  ad- 
dition, Ive hoped that the temporal grouping 
would provide further understanding of .  the 
underlying peripheral nerve pathophysiology in 
AIDP. 
MATERIALS AND METHODS 
Clinical and electrodiagnostic records were re- 
viewed of all patients evaluated b y  the Keurol- 
ogy Departments at the Medical College of Wis- 
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consin (July 1977 through June 1979) and by the 
Neurology and Physical Medicine and Rehabilita- 
tion Departments at the Univcrsity of Michigan 
Medical Center (July 19'78 through J u n e  1 9 3 )  
and found t o  have a final clinical diagnosis of 
AIUP. Only pat.ients 3 years of age and older who 
fulfilled conventional diagnostic clinical crite- 
r i a : ~ - f ~ . i 2 . 1 , ~ . ~ . " . 2 X  were included. Criteria required 
demonstration of weakness of multiple limbs 
(ranging from rriild weakness of legs to complete 
paralysis of all extremity, bulbar, facial, arid trunk 
muscles) arid areflexia oI definite hyporeflexia. 
Progression of weakricss during the initial phase of 
the illness, plateauing by week 6, also was required. 
Features strongly supportive of a diagnosis of 
AIDl' were identical to those described by As- 
symptoms and signs, cranial nerve involvement 
(particularly facial), improvement after ii plateau 
phase, autonomic involvement, and absence of fe- 
ver- at onset of neurologic symptoms (unless a 
specific cause of transient fever was identilied). Ya- 
tients with any suggestion of central nervous sys- 
tem involvement were excluded. 'Transient blad- 
der impairment was not considered to be 
exclusionary. All patients had cerebrospinal fluid 
evaluations; greater than 40 mononuclear leuko- 
cytes/cu mm would have result.ed in exclusion. Fol- 
lowing the initial selection process, all records were 
reviewed to identify patients with other disorders 
t)ury,"'" . including relative symmetry, mild sensory 
known to be associated with polyneuropathy. Ex- 
cludecl were patients with evidence of monoclonal 
gamniopathy (8 patients), systemic lupus ery- 
thematosus (l) ,  lymphoma (l), diabetes mellitus 
( Z ) ,  renal disease ( l ) ,  chronic alcohol abuse (11, 
acute internlittent porphyrka ( I ) ,  arid arsenic intox- 
ication (1) .  Also excluded were 30 patients having 
a final clinical diagnosis of chronic inflamniat.ory 
demyelinating polyradiculorieurop~~thy. N o  r-e- 
maining patient had clinical or historical e\ '1 'd ence 
of abnormal porphyriri metabolism, hexacarbon 
abuse, diphtheritic infection, poliomyelitis, botu- 
lism, or lead neuropathy. 
All patients had one or  more electrodiagnostic 
evaluat.ions, and the majority of studies were peI- 
formed by one of the authors. All other studies 
were performed by electromyograpliers at the 
University of Michigan Medical Center. Elec- 
trodiagnostic reports were reviewed, including t he 
original data sheets, to obtain measures of tenipo- 
ral dispersion, limb temperature, etc., that were 
not included in the final reports. Because stan- 
dardized techniques and protocols existed at both 
institutions (Table l), data collection was relatively 
uniform, although not all patients had the coin- 
plete evaluation as outlined in Table 1. 
Motor and sensory conduction studies were 
performed using the stantlard technique of 
supraniaxinial percutaneous stimulation and sur- 
face electrode recording. Compound muscle ac- 
Table 1. Inflammatory demyelinating polyradiculoneuropathy: electrodiagnostic protocol 
Conduction studies* 
1 Test most involved site when mild or moderate, least involved i f  severe 
2. Peroneal motor (extensor digitorum brevis); stimulate ankle and knee. Measure F-response 1atency.t 
3 If abnormal, tibial motor (abductor hallucis); stimulate ankle and knee Measure F-response latency 
4. If no responses: 
a. Peroneal motor (anterior tibial); stimulate fibula and above knee 
b. Ulnar motor (hypothenar); stimulate elbow and wrist Measure F-response latency. 
c. Median motor (thenar); stimulate elbow and wrist. Measure F-response latency. 
5. Sural sensory (ankle): stimulate 14 cm from recording electrode; perform conduction velocity unless amplitude supernormal. 
6. Median sensory (index); stimulate wrist and elbow. If antidromic response is absent or focal entrapment is suspected, record 
7 .  Additional peripheral nerves can be evaluated if findings are equivocal. Definite abnormalities should result in: 
from the wrist stimulating the palm. 
a. Evaluation of contralateral extremity. 
b. Proceeding to evaluation of specific suspected abnormality. 
a. Facial motor (orbicularis oculi); stimulate at angle of jaw. 
b. Blink reflex studies (orbicularis oculi); stimulate supraorbital nerve. 
8. If prominent cranial involvement: 
Needle examination 
1. Examine anterior tibial. medial gastrocnemius, abductor hallucis, vastus lateralis. biceps brachii. interosseous (hand), and 
2. Any abnormality should be confirmed by examination of at least one contralateral muscle. 
lumbar paraspinal muscles. 
'Words in parentheses indicate recording site for conduction studies 
t A / /  F-response iatency measurements are for distal stlrnuiation sites oniy. 
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tion potential (CMAY) and sensory nerve action 
potential (SNAP) amplitudes were measured from 
baseline to negative peak and were reported for 
sthulation at distal and proximal sites. Conduc- 
tion velocity was measured in the forearm or leg 
segment, and distal latencies were converted to 
“terminal conduction velocity” by dividing the dis- 
tance by the terminal latency. Temporal dispersion 
was estimated by recording the ratio of the prox- 
imal to the distal CMAP, recognizing that a 
reduced proximal to distal CMAP ratio can be at- 
tributed both to temporal dispersion and/or con- 
duction block in some fibers.“’ Measurements of 
CMAP duration would be useful in determining 
the contribution of temporal dispersion, but were 
not available retrospectively. F-response latencies 
were tneasured as the minimal latency in a series of 
10- 13 F-responses using distal (wrist or ankle) 
antidromic motor nerve stimulation. Skin temper- 
atures were measured and maintained above 32”C, 
using either warm compresses or an infrared 
heater. 
Needle electrom yography recordings were per- 
formed using standard concentric needle elec- 
trodes. Fibrillation potentials and positive waves 
were graded from 0 to 4 +  using conventional 
methods: 0, no fibrillation; 1 +, persistent single 
trains in at least two areas away from the endplate; 
2 + ,  moderate numbers in three or more areas; 
3 + , many in all areas; 4 + , filling the baseline in all 
areas. Motor unit action potential (MUAP) recruit- 
ment, amplitude, and configuration (percentage 
polyphasia) were graded subjectively using a 3- 
point interval scale (0-4 + ) coinciding to zero, 
slight, mild, moderate, or severe. For recruitment, 
4+ was equivalent to normal; for amplitude re- 
cordings, 4 + was equivalent to marked increase; 
for spontaneous activity and configuration, 0 was 
equivalent to normal. 
All findings were summarized as a function of 
time following the onset of first neurologic sym- 
toms. Weekly intervals were used for the first 5 
weeks. Thereafter, data were comhined for weeks 
6-10, 11-15, 16-25, 26-3.5, and 36-.50, respec- 
tively. Data for studies performed more than 50 
weeks after onset were reviewed, but these 34 stud- 
ies are not included in the figures because of the 
variable recording intervals. Conduction study re- 
sults from individual nerves were expressed as a 
percentage of the normal mean for each nerve and 
then averaged for motor and sensory studies. h’ee- 
dle electromyographic data were sirnilarly com- 
bined and expressed as an average for distal and 
proximal muscles. All data in a given time interval 
(e.g., 6- 10 weeks) were then averaged, recogriiring 
that such averages tend to deemphasize abnor- 
malities in any multifocal, nonhomogeneous disor- 
der. In addition, individual electrodiagnostic eval- 
uations were reviewed to determine whether or 
not specific criteria (Table 2) for demyelination 
were met. These criteria were modified from those 
proposed by Kelly. The criteria were selected so  
as to be highly suggestive of demyelination, recog- 
nizing that the distinction between “demyelina- 
tion” and “axonal degeneration” is riot always 
clear. There are situations attributed t o  pure ax- 
onal degeneration and regeneration, during kvhich 
there may be considerable slowing of action poten- 
tial propagation and relative preservation of the 
evoked response amplitude. Nevertheless, the 
combined criteria were felt to  have substantial con- 
sensual validity, provide consist.ency with prior 
electrodiagnostic measures of “demyelination,” 
and insure a small likelihood of misrepresenting 
the data. 
RESULTS 
Clinical. There were 32  male and 38 female pa- 
tients, having an average age of 37 years (range 3- 
82 years). An antecedent illness was reported by  
~ ~ ~ ~ ~~ 
Table 2. Criteria suggestive of demyelination in the electrodiagnostic evaluation of acute inflammatory 
demyelinating polyradiculoneuropathy 
Demonstrate at least one of the following in two or more nerves (exceptions noted) 
A Conduction velocity less than 95% of lower limit of normal if amplitude exceeds 50% of lower limit of normal less than 85% 
i f  amplitude less than 50% of lower limit of normal (1) 
B Distal latency exceeding 110% of upper limit of normal i f  amplitude normal exceeding 120% of upper limit of normal i f  
amplitude less than lower limit of normal (2) 
C Evidence of unequivocal temporal dispersion or a proximal to distal amplitude ratio less than 0 7 (2,3) 
D F-response latency exceeding 120% of upper limit of normal (1 2) 
Exceptions 
1 Excluding isolated ulnar or peroneal nerve abnormalities at the elbow or knee, respectively 
2 Excluding isolated median nerve abnormality at the wrist 
3 Excluding the presence of anomalous innervation (e g , median to ulnar nerve crossover) 
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75% of patients within the 2 months prior to onset. 
The interval from the onset of antecedent illness 
to first neuropathic symptom averaged 11 days 
(range 1-42 days), and the interval from first 
neuropathic symptom to plateau of neurologic im- 
pairment averaged 15 days (range 2-33 days). 
Ten patients remained ambulatory; 9 of the 10 
required assistance in walking. The tenth am- 
bulatory patient had primary bulbar involvement. 
Mechanical respiratory assistance was required for 
34% of patients and averaged 39 days (range 1- 
274 days). Autonomic dysfunction (instability of 
blood pressure or bowel or  bladder abnormali- 
ties) occurred in 36% of patients. Muscle stretch 
reflexes were unobtainable at some time during 
the illness in all but 11 patients; those 1 1  had trace 
to hypoactive reflexes. NO pathologic reflexes were 
recorded. Cerebrospinal fluid (CSF) total protein 
was elevated in all but three patients. The average 
CSF total protein was 139 mg/dl (range 25-522). 
The average number of CSF white blood cells was 
3.0 (range 0-38). 
One patient died of a severe superimposed re- 
spiratory infection. The duration of hospitalization 
for the remaining patients averaged 8 1 days (range 
13-408 days). Total recovery was reported for 
64% of patients; remaining patients had evidence 
of mild to severe (nonambulatory) neurologic im- 
pairment at 6-36 months after onset. During this 
interval, two patients (3%) had an unequivocal 
relapse. 
Elettrodiagnosis. Conduction study results are 
shown in Table 3 and Figures 1 through 4, respec- 
tively. Of these 70 consecutive patients with AIDY, 
conduction abnormalities were evident in the nia- 
jority of patients from the time of initial evalua- 
tion. During the first 5 weeks of- illness, motor con- 
duction study abnormalities (abnormal CMAP 
temporal dispersion and/or conduction block, re- 
duced amplitude, conduction velocity or terminal 
conduction velocity, and prolonged or absent F- 
responses) were more common than sensory con- 
duction abnormalities. Normal conduction studies 
were unusual, and only one patient had no abnor- 
mality of conduction during the first 5 weeks of 
illness. Using the pooled data in Table S ,  the nadir 
of abnormality occurred during the third week for 
Table 3. Motor and sensorv conduction studies in lsatients with AlDP evaluated 1 week to 12 months after disease onset. 
Time (weeks] after disease onset 
1 2 3 4 5 6-10 11-15 16-25 26-35 36-50 
A Results for given time interval (weeks) after disease onset' 
Conduction studies(N) 8 18 26 25 19 19 8 6 12 
Motor conduction 
Amplitudet 4 6 ~ 1 3 1  2 8 2 6 1  2 6 2 4 1  3 8 ? 5 9  3 2 2 6 2  3 5 2 6 9  5 0 2 1 0 3  6 6 2 1 5 5  6 2 ~ 1 1 3  
Conduction velocityt 88 i- 5 3  87 2 2 8  72 2 2 6 77 z 3 4  76 2 2 8  72 2 4 4  82 I 3 9  83 z 7 3  82 i 4 3  
Terminalconduction 85 z 6 9  88 r 6 5  6 4 2  3 4  68t 4 7  6 7 2  6 4  67 t 6 9  7 9 t  9 2  83 f 7 3  7 6 2  5 5  
velocity? 
Fresponselatency$ 9 4 ~  2 8  1 1 2 2  6 9  1 2 5 * 1 0 4  1 3 4 ~ 1 8 0  1 3 2 ~ 1 4 1  1 2 7 ? 1 1 2  1 1 6 1 1 2 1  1 1 4 2  8 4  1 0 5 t  5 5  
Temporaldispersion§ 77% 4 5  69 - t  4 1  6 7 2  4 1  6 6 2  6 4  76t 3 9  6 7 k  6 1  7 3 ~  7 1  8 6 t  4 0  7 9 5  4 2  
Amplitudet 8 2 ~  138  7 9 t  1 0 6  50 t 7 3  30 I 5 6  3 7 +  6 9  3 8 2  1 0 3  45 t 1 0 2  6 6 1  2 7 0  6 2 2  9 9  
Conduction velocityt 101 ? 2 1 96 z 2 7  99 z 3 7 90 2 3 7  91 2 3 2  90 t 4 9  91 ? 6 0  99 t 8 7  97 f 3 3  
Terminalconduction 1 0 5 2  3 5  1 0 3 2  4 1  9 3 ~  4 0  9 1 2  3 5  9 4 ~  2 7  8 4 2  5 7  9 2 2  7 2  9 7 2 1 2 0  9 4 2  4 4  
Sensory conduction 
velocityt 
B Percentage of patients fulfilling criteria for demyelination and percentage of patients with abnormal motor or sensory studies for given time (weeks) after onset 
Demyeiination present 
Yes 50 50 85 68 63 63 63 67 25 
NO 12 28 7 5  16 1 1  16 37 33 50 
Indeterminate 38 26 7 5  16 26 21 0 0 25 
Percentage of patients with 
Abnormal motor 88 89 96 92 91 89 75 83 90 
Abnormal sensory 25 39 73 72 68 83 43 60 60 
Both normal 12 6 4 8 5 0 0 17 17 
5 
79 Z 20 1 
9 5 2  4 9  
88t 7 6  
925 6 9  
8 5 2  3 2  
76 * 10 1 
8 9 2  1 7  








'Mean ? SEM 
+Percentage of normal mean 
*Percentage of upper limit of normal 
§Proximal to distal CMAP amplitude x 100 
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FIGURE 1. Motor (white bar) and sensory (striped bar) 
evoked response amplitudes expressed as a percentage of 
the normal mean as a function of time after disease onset in 
patients with acute inflammatory demyelinating polyradic- 
uloneuropathy. The responses are significantly ( P  < 0.05) 




motor conduction studies and during the fourth 
week for sensory conduction studies. Figuie 1 
compares CMAP arid SXAP amplitudes, ex- 
pressed as a percentage of the norm' '1 1 mean, as a 
function of time after disease onset. There is a 
significant ( P  < 0.05) difference between the t w o  
measures, with the SNAP amplitude exceeding the 
CMAP amplitude during the first 3 weeks o f  ill- 
ness. Thet eafter, the) are indistinguishable. Ex- 
amination of the original data demonstrated that 
motor abnormalities within a given patient were 
100 
- -  
s 
W 7 80- 
0 - r -  
5 -  
2 60 
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3 5 6-10 I1 15 I 
TIME (Weeks) 
FIGURE 3. Sensory nerve action potential conduction veloc- 
ity (white bar) and terminal conduction velocity (striped bar) 
as a function of time after disease onset in patients with 
acute inflammatory demyelinating polyradiculoneuropathy, 
expressed as a percentage of the normal mean. 
i 
2 3 4 5 6.10 11-15 16 25 26 35 36 50 
TIME (Weeks) 
FIGURE 2. Compound muscle action potential conduction 
velocity (white bar), terminal conduction velocity (striped 
bar), and temporal dispersion (solid bar) as a function of time 
after disease onset in patients with acute inflammatory derny- 
elinating polyradiculoneuropathy. The conduction velocities 
are expressed as a percentage of the normal mean. Temporal 
dispersion is expressed as a ratio of the proximal to distal 
compound muscle action potential amplitudes x 100. 
more likely to be homogeneous, with the lower 
limbs showing greater involvement than the up- 
per limbs. Sensory conduction studies, on the 
other hand, were more likely t o  demonstrate all- 
nommalities of individual nerves, rvith other nerves 
being normal. Comparison of sural and median 
sensory conduction studies is shown in 71'able 4. At 
the time of initial evaluation during the first 4 
weeks of illness (39 patients), t.he most common 
finding was an abnormal median sensory response 
(usually an absent or markedly reduced SSAP am- 
plitude with reduced terminal conduction velocity) 
with normal sural conduction studies. In a smaller 
proportion of patients, both sensory conduction 
studies were either normal or abnormal. No pa- 
tient had abnormal sum1 and normal median sen- 
I 1  
1 
TIME (Weeks) 
FIGURE 4. F-response latency as a function of time after 
disease onset in patients with acute inflammatory demy- 
elinating polyradiculoneuropathy, expressed as a percent- 
age of the upper limit of normal. 
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Table 4. Comparison of median and sural sensory conduction studies in patients with acute 




All studies (first 4 weeks) FOIIOW-UP 
(N = 86) (39) (39) 
Both normal 30 (35%) 11 (28%) 13 (33%) 
Both abnormal 20 (23%) 9 (23%) 13 (33%) 
Median abnormal 36 (42%) 19 (49%) 13 (33%) 
and sural normal 
sural abnormal 
Median normal and 0 ( 0%) 0 ( 0%) 0 ( 0%) 
sory studies, a finding that is characteristic of most 
mild chronic sensory polyneuropathies. 
Using the criteria for the presence of demye- 
lination, 50 (7 1%) patients had unequivocal elec- 
trodiagnostic evidence of a demyelinating polyneu- 
ropathy (Table 5). In addition, 11 patients (1696) 
fulfilled the criteria for deniyelination in a single 
nerve, after excluding isolated ulnar, peroneal, or 
median abnormalities at common sites of entrap- 
ment. In  all 1 1 patients, the electrornyographe1- 
used the term “demyelinating” in the interpreta- 
tion of the evaluation, although the complete pro- 
tocol, as outlined in Table 1, was not completed. In 
all, abnormalities of conduction velocity were strik- 
ing, and none could be considered borderline. 
Therefore, as many as 87% of the 70 patients had 
evidence of‘ a demyelinating neuropathy. Seven 
additional patients (lo%,) had indeterminate evalu- 
ations, usually demonstrating isolated abtior- 
malities, such as abnormal dispersion, borderline 
reduction in conduction velocity, or  absent evoked 
responses. In these patients, it was neither possible 
to conclude that demyelination was present nor to 
exclude the possibility with a high degree of cer- 
Table 5. Electrodiagnostic evidence suggestive of 
demvelination in 180 studies of 70 Datients with AlDP 
Presence of demyelination: 
(multiple nerves) 
(single nerve)‘ 
borderline reduction in conduction velocity, 
absent evoked responses) 
Fulfilled criteria for axonal degeneration onlyt 
Fulfilled criteria for demyelination 50 (71%) 
Fulfilled criteria for demyelination 11 (16%) 
Indeterminate (isolated abnormal dispersion, 7 (10%) 
2 ( 3%) 
‘Electromyographer diagnosed “demyelination” in all of these studies; 
evoked responses often absent in other nerves studied. A/ /  patients had 
only one study performed 
tB0th patients had five or more studies over a 30-week period. 
tainty. For example, one patient had completely 
absent CMAP and SNAP evoked responses. re- 
cording from distal and proximal extremities ;is 
well as facial muscles. ‘I’hese studies, perfi)rmed 
during the fourth week of illness, do not preclude 
the possibility that evidence of demyelination 
would have been present on earlier studies. Two 
patients had definite evidence of axonal degenera- 
tion only, with preservation of conduction velocity 
(proximal and distal) and F-response latencies, 
without evidence of temporal dispersion. Both pa- 
tients had multiple studies ( 3  arid 8, respectively) 
over an interval of 1-30 weeks. 
duction velocity, F-response latency, and temporal 
dispersion for the 70 patients wit.h AIDP tiemon- 
strated slight variation over the evaluation period. 
The motor conduction velocity and terminal con- 
duction velocity data, together with the amount of 
temporal dispersion, are presented in Figure ‘2 a s  a 
function of time after disease onset, demonstrating 
a maximum impairment in all measures between 
the third and eighth weeks. Of interest, a h o r -  
nialities of conduction velocity at the 20th week 
after onset were similar to the impairment at week 
2. In other words, conduction velocity, at a time 
when clinical improvement wias substantial, was in- 
distinguishable from conduction abnormalities 
early in the course of the disease. This is in contrast 
to  the CMAP amplitude data that demonstrated 
significant improvement by the 20th week when 
compared to initial responses. Frequent examples 
of progressive slowing of conduction velocity were 
documented in patients who were well into their 
recovery stage. Sensory conduction velocity and 
terminal conduction velocity are shown in Figure 
3, demonstrating similar, but less striking, abnor- 
mality compared to motor studies. 
F-response latencies as a function of time after 
disease onset are shown in Figure 4. The most pro- 
d con- Measures of conduction velocity, terliiin, 1 
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FIGURE 5. Motor unit action potential recruitment score for 
proximal (white bar) and distal (striped bar) muscles as a 
function of time after disease onset in patients with acute 
inflammatory demyelinating polyradiculoneuropathy. Re- 
cruitment is expressed from 0 (absent) to 4+ (normal). 
longed latencies were recorded during the third to 
fifth weeks after onset. These results are mislead- 
ing, because absent F-responses were common 
early in the course of illness. Because of the wide 
range of results, the latency measurements for the 
different evaluation periods were not significantly 
different. Within a given patient, however, results 
were relatively uniform, and individuals with 
marked prolongations in one nerve usually had 
either absent responses or similarly prolonged 
latencies in other nerves. 
' Ihe results of needle electromyography are 
shown in Figures 3 through 8. The earliest abnor- 
mality was decreased PvlUAP recruitment, without 
TIME (Werhrl 
FIGURE 7. Motor unit action potential polyphasia as a func- 
tion of time after disease onset in patients with acute inflam- 
matory demyelinating polyradiculoneuropathy. The percent- 
age of polyphasic potentials in proximal (white bar) and 
distal (striped bar) muscles is expressed from 0 (normal) to 
4+ (marked increase). 
TIME (Weekrl  
FIGURE 6. Abnormal spontaneous activity in proximal (white 
bar) and distal (striped bar) muscles as a function of time 
after disease onset in patients with acute inflammatory demy- 
elinating polyradiculoneuropathy. Fibrillation scores range 
from 0 to 4 + ,  with 0 = none and 4+ = profuse fibrillation 
potentials in all areas of muscle. 
abnormality of configuration or evidence of <t ' I ,nor- 
ma1 spontaneous activity. Overall, recruitment ah- 
normalities were most prominent distally (Fig. 5), 
although there were individual patients with pro- 
found proximal involvement of some niuscles and 
minimal findings distally. KO patient had normal 
MUAP recruitment at the time of initial examina- 
tion. MUAP recruitment scores gradually im- 
proved, but the slow improvement did not reflect 
the overall clinical improvement of these patients, 
particularly late in the course of the disease. 
Abnormal spontaneous activity appeared be- 
tween the second and fourth weeks following 
disease onset (Fig. 6). Fibrillation potentials and 
d 
~ 11-15 
i l  i 
TIME (Weeha1 
FIGURE 8. Motor unit action potential amplitude as a func- 
tion of time after disease onset in patients with acute inflam- 
matory demyelinating polyradiculoneuropathy. Amplitude in 
proximal (white bar) and distal (striped bar) muscles is ex- 
pressed from 0 (normal) to 4 +  (marked increase). 
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positive waves were recorded, on the average, 
simultaneously in distal and proximal muscles. 
Proximal fibrillation potentials were maximal be- 
tween the sixth and tenth weeks, with distal 
fibrillation reaching a maximum between the 1 Ith 
and 15th weeks. Thereafter, abnormal spontane- 
ous activity slowly diminished. 
MUAP configuration is described in Figures 7 
and 8. The earliest abnormality was an increased 
percentage of polyphasic MUAPs during the 
fourth week for both proximal and distal muscles 
(Fig. 7). The greatest percentage of abnormal 
polyphasid was recorded between the 9th and 15th 
weeks of illness, with a decrease thereafter. By 
comparison, increased MUAP amplitude became 
apparent between the fourth and fifth weeks, 
reaching a maximum between the 11 th and 35th 
weeks (Fig. 8). Subsequent studies showed a return 
toward normal in both proximal and distal mus- 
cles. 'The improvement was most apparent in the 
34 studies performed 1-3 years after disease on- 
set. In several patients, small low-amplitude, highly 
polyphasic MUAPs were reported during the sec- 
_1.2mv 
I sec 
_I . 2 m ~  
2 sec 
ond month of illness, likely representing re- 
generating axons. 
Finally, four patients were found to have ab- 
normal spontaneous activity, consisting of niyoky- 
mic discharges, during the first 3 weeks of illness. In 
two, myokymic discharges were recorded from fa- 
cial muscles in conjunction with clinically apparent 
facial myokymia. In the remaining two, myokyniic 
discharges were recorded from limb muscles in the 
absence of clinical myokymia (Fig. 9). In all, the 
myokymic discharges were a transient finding, oc- 
curring within the first 3 weeks of illness and ab- 
sent on subsequent examination. 
DISCUSSION 
Lambert and Mulder "' reported electrodiagnostic 
evaluations on 49 patients with a clinical diagnosis 
of AIDP. 'The studies were performed during the 
first 3 weeks of illness, 14% of- patients had no 
abnormality of conduction, 6 1 % had conduction 
velocity less than 70% of the normal mean, and 
25% had prolonged distal latencies only without 
substantial abnormality of conduction velocity. 
.2mv 
200 m s  
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FIGURE 9. Myokymic discharges recorded from an extremity muscle during the second week of illness in two patients (top and 
bottom) with acute inflammatory demyelinating polyradiculoneuropathy. Clinical myokymia was not apparent. The recordings 
were made using a conventional concentric needle electrode. The discharges were not under voluntary control. 
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McLeod"' reported similar findings in 1 14 pa- 
tients, indicating that marked slowing of conduc- 
tion velocity or an abnormally prolonged motor 
distal latency consistent with demyelination was 
found in one or  more nerves in 50% of patients. 
Asbury.' indicated that approximately 80% of 
AIDP patients have evidence of- nerve conduction 
slowing or block at some point during their illness, 
although up to 20% of patients will have "normal 
conduction studies." The combined data for weeks 
1-3 from the current study is similar to that re- 
ported above, although normal studies were less 
comnion and evidence of' demyelination was more 
frequently present, presumably because of the in- 
creased likelihood of detecting an abnormality 
with repeat studies. The criteria of reporting de- 
myelination when conduction velocity was 70% of 
the normal mean is approximately equivalent to 
our criteria using 83% of lower limit of normal. We 
prefer the latter because most laboratories have 
well-established upper and lower limits of normal; 
normal means are less frequently identified. Sev- 
eral patients had abnormal distal latency (terminal 
conduction velocity) without abnormality of con- 
duction velocity in the forearm or leg segment of 
the extremities. Of six such patients, five subse- 
quently demonstrated evidence of diffuse slowing 
of conduction velocity. 
Motor fibers are clinically involved more fre- 
quently than sensory fibers,"' 1.25*28 and sensory 
evoked responses may be entirely normal in pa- 
tients having prominent motor abnormalities. 
Nevertheless, median or  ulnar SNAPs have been 
reported to be absent in 5 8 %  of patients," with 
abnormalities of sensory conduction (abnormal 
SNAP amplitude or evidence of demyelination) re- 
ported in 76% of patients." The largest elec- 
trod iagnostic discrepancy between motor and sen- 
sory abnormalities occurs during the first 2 weeks 
after disease onset, as judged by either evoked re- 
sponse amplitudes or percentage of patients hav- 
ing abnormal motor or sensory studies. Inter- 
estingly, SNAPs may be abnormal or absent in 
certain nerves (e.g., median), yet normal in others 
(e.g., sural).'2 The relative sparing of surd1 re- 
sponses in the presence of abnormal median sen- 
sory responses is atypical of any diffuse poly- 
neuropathy. This finding, in association with an 
appropriate clinical syndrome, suggests the diag- 
nosis of AIDP. 
Several possibilities exist that can explain the 
discrepancy between motor and sensory studies, as 
well as the discrepancy between sural and median 
sensory conduction studies. If the size of the my- 
elinated fiber or the amount of' rriyeliri were sonie- 
how protective in AIDP, either b y  protecting the 
axon or preserving conduction, the large myelin- 
ated sensory fibers could be preser1d rel;iti\t t o  
the smaller motor fibers. This could explain pro- 
longed function in sensory compared t o  niotor 
fibers, as well as the apparent distal fiber predilec- 
tion. Similarly, it could explain prolonged surd 
nerve function as compared t o  median sensory 
function, considering the size of the sural nerve at  
the ankle recording site as compared to the termi- 
nal fibers of the median sensory nerve at the digit 
recording site. 'The apparent distal predilection is 
consistent with previous reports describing a cen- 
tripetal pattern of demyelination in some patients 
occurring first in the distal nerve arid progress- 
ing to the spinal root.'" These findings also are 
consistent with the experimental observations of 
Sumner,29 who studied humorally induced tleniy- 
elination in rat sciat.ic nerve. Smaller diameter 
myelinated fibers were affected earlier arid more 
completely than larger diameter fibers. I n  addi- 
tion, nerve roots were highly permeable to anti- 
serum, and distal motor nerve twigs anti coniriion 
compression sites were identified as potential areas 
of vulnerability because of an impaired blood- 
nerve barrier. 
Conversely, a model can be proposed in which 
sensory fibers are initially unaffected, with the tlis- 
ease involving motor fibers only. In an)- mixed 
nerve, an inflammatory response involving motor 
fibers could be associated with intraneural edema 
and compression of- sensory fibers only as an 
epiphenomena. In such a model, sensory fibers 
could hypothetically be compressed at known sites 
of anatomic vulnerability. 'lhis would be consistent 
with the known sensitivity of diseased nerve at 
common compression sites, but would not explain 
the observation that sensory evoked potentials may 
demonstrate proximal slowing (between Erb's 
point and the cervical cord) at a time when sensory 
conduction is normal more distally." Secondary 
sensory involvement also would not explain the se- 
quential abnormalities reported on sural nerve 
biopsy in AIDP.23 Of importance, however, is the 
demonstration that a single screening sun1 sensory 
conduction study, as is commonly done in the 
evaluation of chronic sensory polyneuropathies, is 
inadequate in the evaluation of patients with SUS- 
pected AIDP. 
As reported by others,' partial conduction 
block and increased temporal dispersion of motor 
evoked responses were helpf-ul in establishing the 
presence of demyelination, particularly early in the 
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disease when maximum conduction velocities were 
often within the normal range or only slightly re- 
d~ced . ' . '~  Abnormal temporal dispersion can be 
explained by multifocal demyelination of individ- 
ual axons, resulting in some fibers having little or 
no demyelination and other fibers having multiple 
areas of demyelination. 'These differences are ac- 
centuated by measuring conduction over sequen- 
tially longer distances. With short stimulation to 
recording site distances, the differences may be 
small and the CMAP may appear normal. With 
longer stimulation to recording distances, the in- 
creased range of conduction velocities results in 
the initial component of the CMAP (representing 
the fastest fibers) being greatly separated from the 
trailing portion of the CMAP (represenhg the 
slowest conduction in the most demyelinated 
fibers). This results in both a prolonged response 
and a markedly reduced CMAP amplitude with 
proximal stimulation. The amplitude may be re- 
duced even further with progressive conduction 
block. The likelihood of continuous signal propa- 
gation along the nerve decreases with increasing 
nerve length. Temporal dispersion alone cannot. 
always account for the observed decrease in CMAP 
amplitude; progressive conduction block with 
longer stimulation to recording distances may ac- 
count for much of the amplitude reduction. 
Needle electromyography findings are not fre- 
quently reported in AIDP. The initial findings in 
any patient with AIDP who has clinical weakness 
may consist only of abnormal recruitment, with 
the degree of abnormality being proportional to 
the degree of clinical weakness. Keported needle 
electromyography abnormalities 3-4 weeks after 
onset are similar to  our findings and range from 
evidence of reduced recruitment only to extensive 
denervation with profuse positive waves arid 
fibrillation potentials.'8 Axonal degeneration pre- 
suniably may occur at any time during the progres- 
sion of the disease, which averages 2-3 weeks and 
rarely exceeds 4 weeks.'' If degeneration of an in- 
dividual axon occurred proxinially, it could then 
take an additional 3 weeks for the appearance of 
fibrillation potentials in distal muscles innervated 
by that axon. The simultaneous appearance of 
fibrillation potentials, on the average, in proximal 
and distal muscles can best be explained by a 
model where axonal degeneration occurs ran- 
domly along the axon or at the distal nerve ending. 
These findings are different from those associated 
with the polyneuropathy of acute intermittent por- 
phyria, a disorder felt to have initial involvement at 
the anterior horn cell.' In porphyric neuropathy, 
fibrillation potentials appear within 2-3 weeks in 
paraspinal muscles and then subsequently appear 
in more distal muscles over the next several weeks. 
Similar findings are associated with any proximal 
axonal lesion. Fibrillation potentials first appear in 
those muscles closest to the lesion and later occur 
in more distal muscles. The subsequent decrease in 
the amount of abnormal spontaneous activity 
probably reflects reinnervation from either col- 
lateral sprouting3' or  even axonal regeneration, 
when the initial axonal damage occurred close to 
the muscle being reinnervated. A reduced number 
of fibrillation potentials in proximal, compared 
to distal, muscles can be explained both by the 
smaller probability that a long segment of axon 
would have regenerated arid by the higher mean 
recruitment in proximal compared to distal mus- 
cles, increasing the likelihood of collateral rein- 
nervation. Again, the figures represent overall 
averages, there being many patients who demon- 
strated only minimal abnormal spontaneous activ- 
ity throughout the course of their disease, and 
other patients who had 4 + fibrillation potentials iii 
both proximal and distal muscles for prolonged 
periods. 
The earliest abnormality of' MUAP con- 
figuration was an increased percentage of poly- 
phasic MUAPs during the fourth week in both 
proximal and distal muscles. -1'he greatest percent- 
age of abnormal polyphasia was recorded between 
the 9th and 15th weeks of illness, with a decrease 
thereafter. By comparison, increased MUAP ani- 
plitude became apparent between the fourth and 
fifth weeks, reaching a maximum between the 1 1 th 
and 35th weeks. Subsequent studies showed a re- 
turn toward normal. Again, abnormalities were 
recorded in both proximal and distal muscles. In 
several pat.ients, small low-amplitude, highly 
polyphasic MUAPs were reported during the 
second month of illness, likely representing 
regenerating axons. 'I'he findings are comparable 
to those described by Rallantyne arid Hansen' and 
are consistent with a model in which surviving ax- 
ons reinnervate denervated muscle fibers and then 
undergo a process of remodeling as regenerating 
axons reach the muscles. They further denion- 
strated that some patients showed evidence of poor 
reinnervation, whereas others had motor unit 
studies that returned to normal during that time. 
Unlike conventional experience with illnesses in- 
volving the motor neuron (e.g., prior polio, slowly 
progressive motor neuron disease), MUAP config- 
uration and amplitude were shown to progres- 
sively improve, and they suggested that ongoing 
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remodeling of’ previously large motor units re- 
sulted in return to normal size as reinnervation 
progressed. Their sequential studies indicated a 
slow increase in MUAP area 2-4 months after on- 
set, at a time when there was a modest increase in 
MUAP recruitment. Thereafter, the number of 
motor units stayed constant while there was evi- 
dence of increased MUAP area, which is consistent 
with ongoing collateral reinnervation. New axons 
also may reinnervate surviving muscle fibers that 
have been denervated, in addition to innervating 
those fibers shed by giant units in the process of 
muscle fiber turnover. Using such a model, it is 
easy to predict that total remodeling can occur 
over time, with the electrophysiologic characteris- 
tics returning to normal. In the 34 studies per- 
formed 1-3 years after disease onset, it was not 
unconimon to identify profuse spontaneous activ- 
ity and MUAP abnormalities, most notably, re- 
duced recruitment and increased amplitude, par- 
ticularly in patients who previously had evidence 
of extensive axonal degeneration. This would sup- 
port the suggestion that many patients with exten- 
sive axonal degeneration have failure of axonal re- 
generation or anterior horn cell death.’ 
The earliest abnormal spontaneous activity 
consisted of myokymic discharges recorded in four 
patients. Patients with AIDP often develop a char- 
acteristic persistent quivering of facial muscles, 
unilaterally or bilaterally. The term “m yok) mia” 
has been used to describe these facial movements. 
Myokymic discharges may be recorded from mus- 
cles of such patients.’” These discharges consist of 
spontaneous, semirhythmic bursts of potentials 
that individually resemble MUAPs. Discharge 
rates within the involuntary bursts of normal- 
appearing MUAPs are typically 30-60 Hz, with 
discharges in bursts of 3-  10, recurring regularly 
at intervals of 0.5-3.0 seconds.“’ Myokymic dis- 
charges have also been identified in the absence of 
clinical myokymia in limb muscles of patients with 
AIDP. ’ Myokymic discharges are present only in 
the acute phase of AIDP, and neither myokymic 
discharges nor clinical myokymia has been re- 
ported chronically in patients who have had AIDP. 
The results of local ischemia, peripheral nerve 
block, and percutaneous stimulation in patients 
with limb myokymia suggest that myokymic dis- 
charges arise focally at the site of a focal nerve 
lesion, most likely involving focal demyelination 
with underlying axonal damage. Although several 
explanations have been proposed to account for 
the generation of myokymic discharges, none have 
been demonstrated unequivocally and different 
mechanisms may play a role in different patients. 
Possibilities have included transaxonal, ephaptic 
excitation through an “artificial synapse” formed 
after focal nerve damage and alternatively, 
damaged axons may serve directly as rhythmic, 
oscillating generators of action potentials. Fo- 
cal demyelination also may increase nerve excit- 
ability.” 
Whether or  not a pure axonal form of AIDP 
exists is uncertain. I t  is clear that all reported series 
of AIDP patients have included patients without 
electrodiagnostic evidence of demyelination. Simi- 
larly, it is often difficult to identify evidence of pri- 
mary demyelination on nerve biopsy, further com- 
plicating the issue. Electrodiagnostic evaluation of 
additional nerves, including proximal extremity 
andlor facial nerve or blink reflex studies, niay 
provide evidence suggestive of a demyelinating 
component to the neuropathy. In other instances, 
complete evaluation, and even sequential studies 
over many weeks, demonstrate only findings com- 
patible with axonal degeneration alone. I n  o u I  
study, patients who fulfilled criteria suggestive of 
demyelination had an average of 2.4 electrodiag- 
nostic studies, with less than half having only a 
single evaluation. By comparison, patients fulfill- 
ing the criteria for demyelination in a single nerve 
had an average of 1.4 studies, with 90% having 
a single evaluation. Patients with indeterminate 
evaluations had an average of 1.4 studies, with 
71% of them having a single study. As ant.icipated, 
the likelihood of demonstrating evidence of demy- 
elination or  excluding its presence increased with 
increasing data, which was acquired both during a 
single evaluation and during repeat studies. It is 
possible that the 11% of patients with indetermi- 
nate evaluations could have been more completely 
categorized given additional evaluation. Never- 
theless, a small percentage of patients had evi- 
dence of axonal degeneration only. In the two 
patients described who had no electrodiagnostic 
evidence of demyelination, adequate axonal func- 
tion remained to record CMAP responses. I t  
would seem unlikely that primary demyelination 
was the initial event, with complete destruction of 
all fibers involved, leaving only normal surviving 
axons with no evidence of demyelination. 
Patients with acute porphyric polyneuropathy 
are often clinically indistinguishable from patients 
with AIDP; in many of them, abnormal porphy- 
rin metabolism is not identified until the second 
episode of polyneuropathy. That these patients 
are clinically indistinguishable from patients with 
AIDP would seem the most compelling evidence 
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that this or similiar disorders may be included in 
most series of AIDP patients. Interestingly, por- 
phyric neuropathy was initially felt to be demy- 
elinating polyneuropathy with superimposed ax- 
onal degeneration. Recently, the demyeliriation 
has been identified as secondary to axonal degen- 
eration, with electrodiagnostic studies demonstrat- 
ing evidence of only axonal degeneration without 
demyelination. Patients with presumed ALDP who 
do not have electrodiagnostic evidence of deniyeli- 
nation should be evaluated thoroughly to exclude 
the possibility of another disorder. 
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